Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry

Pascal Verdier-Pinard1, Fang Wang, Berta Burd

  • 1Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Biochemistry
|October 15, 2003
PubMed

Insights

Tubulin mutations and modifications contribute to cancer drug resistance. Liquid chromatography/electrospray ionization mass spectrometry directly analyzes tubulin in resistant cells, detecting mutations and post-translational modifications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tubulin isotype expression, mutations, and modifications are implicated in Taxol resistance.
  • Previous C-terminal peptide analysis using mass spectrometry provided insights into tubulin diversity.
  • Direct analysis of native tubulins offers a more comprehensive understanding of resistance mechanisms.

Purpose of the Study:

  • To directly analyze native tubulin composition, including post-translational modifications and mutations, in drug-sensitive and drug-resistant human cancer cell lines.
  • To compare tubulin profiles between parental and resistant cell lines using liquid chromatography/electrospray ionization mass spectrometry.
  • To investigate the translation of mutant tubulin alleles in resistant cell lines.

Main Methods:

  • Liquid chromatography/electrospray ionization mass spectrometry (LC/ESI-MS) was employed to analyze native tubulins.
  • Taxol-stabilized microtubules were isolated from parental and resistant human cancer cell lines (A549 and HeLa).
  • Analysis focused on the direct determination of tubulin isotype composition, post-translational modifications, and mutations.

Main Results:

  • Four major tubulin isotypes (betaI-, betaIVb-, Kalpha1-, and alpha6-tubulin) were identified in A549 and HeLa cells.
  • betaIII- and alpha4-tubulin were detected as minor species; alpha4-tubulin was identified for the first time.
  • Alpha-tubulins were highly tyrosinated, with low levels of monoglutamylation observed. betaII- and betaIVa-tubulins were notably absent.
  • Heterozygous expression of Kalpha1- or betaI-tubulin mutants, even with small mass changes, was detected in resistant cell lines.

Conclusions:

  • Direct mass spectrometry analysis of native tubulins provides a comprehensive view of tubulin composition and modifications.
  • The study identified specific tubulin isotypes and modifications in human carcinoma cell lines.
  • Detection of heterozygous tubulin mutants confirms their translation and potential role in drug resistance.